SAS Output

13-JUL-2020 6:10

LYMPH ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1608-FL, TGR-1202/Lenalidomide/CHOP or Benda +Ob 1 Y 1 TGR-1202 + Obinutuzumab 150 18 10 5 1 0 0 01/23/2018 277 98
        2 Lenalidomide + Obinutuzumab   16 8 3 2 1 1      
        3 CHOP + Obinutuzumab   8 2 1 1 0 0      
        4 Bendamustine + Obinutuzumab   6 0 0 0 0 0      
            48 20 9 4 1 1      
 
  S1826-HD, Adv, Age 12+, N+AVD vs BV+AVD 1 Y 1 Nivolumab + AVD 987 75 75 56 30 9 1 08/29/2019 285 131
        2 Brentuximab Vedotin + AVD   74 74 57 28 9 2      
            149 149 113 58 18 3      
 
Yes A051301-ABC DLBCL, Auto HCT and Ibrutinib/Placebo 0 E Total Registrations   58 3 2 1 0 0 10/12/2016 178 70
            58 3 2 1 0 0      
 
    1 E Total Registrations   8 2 1 1 1 0 10/12/2016    
            8 2 1 1 1 0      
 
  E4412-HD, RR, Ipilimumab +Nivo +Brentuximab Vedotin 1 E Total Registrations   8 4 2 1 0 0 04/17/2019 133 56
            8 4 2 1 0 0      
 
  EA4151-Lymph, AHCT +/-Ritux, MRD Neg 0 E Total Registrations   55 27 13 4 2 0 04/03/2018 169 75
            55 27 13 4 2 0      
 
    1 E Total Registrations   42 21 12 5 0 0 04/03/2018    
            42 21 12 5 0 0      
 
  EA4181-MCL, Randomization BR/CR v BR/CR-A v BR-A 1 E Total Registrations   8 8 7 4 1 0 12/13/2019 90 33
            8 8 7 4 1 0      
 
No A051701-LYMPH, MYC/BC2 DHL&DEL, R-chemo+/-Venetoclax 1 E Total Registrations   19 19 17 9 4 1 01/02/2020 212 90
            19 19 17 9 4 1